BIOMAT Database Logo BIOMAT Database Logo

Postexposure antiretroviral treatment for rape survivors? 1997

R Denenberg

UI MeSH Term Description Entries
D011902 Rape Sexual intercourse without consent of the victim.
D003376 Counseling The giving of advice and assistance to individuals with educational or personal problems.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

R Denenberg
Characteristics, treatment, and antiretroviral prophylaxis adherence of South African rape survivors.
September 2007, Journal of acquired immune deficiency syndromes (1999),
R Denenberg
Caring for rape survivors.
January 1998, Nursing times,
R Denenberg
Candidate antiretroviral agents for use in postexposure prophylaxis.
May 1997, The American journal of medicine,
R Denenberg
Post-exposure prophylaxis for rape survivors.
January 2007, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R Denenberg
Understanding rape survivors' preparations for court.
March 1996, Violence against women,
R Denenberg
After rape: who should examine rape survivors?
May 1986, The American journal of nursing,
R Denenberg
Rape treatment programmes: delivering innovative services to survivors.
January 1989, Medicine and law,
R Denenberg
New guidelines for antiretroviral therapy in nonoccupational postexposure prophylaxis.
March 2005, AIDS clinical care,
R Denenberg
Management of rape survivors.
September 1999, The Ceylon medical journal,
R Denenberg
Recovering from rape. Making space for healing is critical for survivors of rape.
January 2002, Positive living (Los Angeles, Calif.),
Copied contents to your clipboard!